Jason A. Leverone - Chief Financial Officer at OnKure Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
OKUR on Nasdaq
All Insider Reports
All Insider Reports

Jason A. Leverone - trading volume in the past year for OnKure Therapeutics, Inc.

Holdings reported by Jason A. Leverone for OnKure Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 16,301 $48,376 $2.97 22 Dec 2025 Direct
Employee Stock Option (right to buy) 65,000 27 Jan 2025 Direct Class A Common Stock

Transactions reported by Jason A. Leverone for OnKure Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.